Cargando…
Role of Immunotherapy in Gastroesophageal Cancers—Advances, Challenges and Future Strategies
SIMPLE SUMMARY: Gastric and esophageal cancers represent a global health concern with considerable associated morbidity and mortality. The management of these malignancies was historically limited to chemotherapy, radiotherapy and surgery. More recently, immunotherapies, which can harness the immune...
Autores principales: | Lynch, Emer, Duffy, Austin G., Kelly, Ronan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670173/ https://www.ncbi.nlm.nih.gov/pubmed/38001661 http://dx.doi.org/10.3390/cancers15225401 |
Ejemplares similares
-
Immune Checkpoint Inhibitors: Changing the Treatment Landscape in Esophagogastric Adenocarcinoma
por: Lynch, Emer, et al.
Publicado: (2023) -
Immunotherapy for Gastroesophageal Cancer
por: Goode, Emily F., et al.
Publicado: (2016) -
Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
por: Park, Robin, et al.
Publicado: (2021) -
The Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer
por: Dadgar, Neda, et al.
Publicado: (2023) -
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
por: Zhao, Zhongwei, et al.
Publicado: (2019)